- Report
- February 2025
- 200 Pages
Global
From €3930EUR$4,490USD£3,416GBP
- Report
- September 2025
- 250 Pages
Global
From €3930EUR$4,490USD£3,416GBP
- Report
- March 2025
- 250 Pages
Global
From €3930EUR$4,490USD£3,416GBP
- Report
- February 2026
- 364 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 373 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 282 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 275 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 275 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 168 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- May 2025
- 110 Pages
Global
From €4157EUR$4,750USD£3,614GBP
- Report
- April 2025
- 225 Pages
Global
From €4371EUR$4,995USD£3,800GBP
- Report
- October 2025
- 160 Pages
Global
From €3457EUR$3,950USD£3,005GBP
- Report
- September 2025
- 150 Pages
Global
From €3369EUR$3,850USD£2,929GBP
€4245EUR$4,850USD£3,690GBP
- Report
- December 2025
- 135 Pages
Global
From €4245EUR$4,850USD£3,690GBP
- Report
- February 2025
- 135 Pages
Global
From €4245EUR$4,850USD£3,690GBP
- Report
- April 2025
- 125 Pages
United States
From €2844EUR$3,250USD£2,473GBP
- Report
- January 2025
- 456 Pages
Global
From €4332EUR$4,950USD£3,766GBP
- Report
- April 2018
- 97 Pages
Global
From €14003EUR$16,000USD£12,172GBP
- Report
- June 2023
- 186 Pages
Global
From €4070EUR$4,650USD£3,538GBP
- Report
- November 2022
- 286 Pages
Global
From €2297EUR$2,625USD£1,997GBP
€4595EUR$5,250USD£3,994GBP

Liver cancer is a type of cancer that originates in the liver, an organ located in the upper right side of the abdomen. It is the fifth most common cancer worldwide and the third leading cause of cancer-related death. Symptoms of liver cancer can include abdominal pain, jaundice, and weight loss. Treatment options for liver cancer include surgery, chemotherapy, radiation therapy, and targeted therapy.
The oncology market for liver cancer is highly competitive, with a range of treatments available. Pharmaceutical companies are investing in research and development to develop new treatments and improve existing ones. Additionally, the market is seeing an increase in the number of clinical trials for new treatments.
Companies in the liver cancer market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more